search
Back to results

CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions

Primary Purpose

Laryngeal Disease, Laryngeal Tumor, Laryngopharyngeal Reflux

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Endo CDx Brush biopsy
Sponsored by
CDx Diagnostics
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Laryngeal Disease focused on measuring Larynx, reflux, LPR, tumor, lesion

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 18 or over
  • patients suspected to suffer from LPR
  • Patients with laryngeal/hypopharyngeal lesions.

Exclusion Criteria:

  • Patient refusal
  • Patients with anatomical variants which precludes biopsy taking.
  • Patients with allergy to lidocain-based local anesthesia agents.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Experimental

    Arm Label

    Brush biopsy for laryngeal lesion

    Brush biopsy for LPR

    Arm Description

    Brush biopsy of the larynx - in addition to the standard biopsy

    Brush biopsy of the larynx at the post cricoid region - in addition to the standard examination for LPR (PH monitoring double probe)

    Outcomes

    Primary Outcome Measures

    Efficacy of EndoCDx brush
    Efficacy of EndoCDx brush biopsy as a diagnostic tool for laryngeal lesions compared to cup forceps biopsy and a diagnostic tool for LPR compared to double probe PH monitoring

    Secondary Outcome Measures

    Assessment of pain
    Assessment of pain during EndoCDx brush biopsy under local anesthesia by Visual Analog Score for pain

    Full Information

    First Posted
    July 10, 2017
    Last Updated
    July 16, 2020
    Sponsor
    CDx Diagnostics
    Collaborators
    Rambam Health Care Campus
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03214835
    Brief Title
    CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions
    Official Title
    CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2020
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    Study halted prematurely, prior to enrollment of first participant.
    Study Start Date
    February 1, 2018 (Anticipated)
    Primary Completion Date
    August 2019 (Anticipated)
    Study Completion Date
    December 2019 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    CDx Diagnostics
    Collaborators
    Rambam Health Care Campus

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The study will take place at Rambam medical center, department of Otolaryngology Head and Neck Surgery, for two years. Patients suspected of LPR or laryngeal l tumor and are candidate for laryngeal or hypopharyngeal biopsies will be recruited.
    Detailed Description
    First- all patients visiting our clinic with laryngeal complaints suspicious for either LPR or laryngeal tumor will fill the RSI questionnaire. Then fiberoptic examination will be performed by a laryngologist that will complete the RFS score. Patients with suspicious lesions will be referred for TFL standard biopsy and CDx brush biopsy in order to determine whether the lesions are malignant or benign. The pathologic diagnosis of invasive carcinoma from a TFL biopsy is considered equivalent to the pathology results from a direct laryngoscopy biopsy. All patients with benign pathology or carcinoma in-situ (CIS) on TFL biopsy will be referred for subsequent direct laryngoscopy (DL) for definitive diagnosis. At the time of the DL biopsy will include also another CDx brush smear. Patients with benign-appearing lesions will be taken for lesion removal and biopsy.Before removal of the lesion a CDx brush smear will be collected. All the participants suspected of LPR will have: PHmetry with Manometry andCDx brush biopsy.All relevant demographic and clinical data will be retrieved for analysis. CDx biopsies will be an addition to the routine management of the patients in the diagnosis and follow-up of laryngeal lesions and LPR and will not replace the standard regimen.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Laryngeal Disease, Laryngeal Tumor, Laryngopharyngeal Reflux
    Keywords
    Larynx, reflux, LPR, tumor, lesion

    7. Study Design

    Primary Purpose
    Screening
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Outcomes Assessor
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Brush biopsy for laryngeal lesion
    Arm Type
    Experimental
    Arm Description
    Brush biopsy of the larynx - in addition to the standard biopsy
    Arm Title
    Brush biopsy for LPR
    Arm Type
    Experimental
    Arm Description
    Brush biopsy of the larynx at the post cricoid region - in addition to the standard examination for LPR (PH monitoring double probe)
    Intervention Type
    Device
    Intervention Name(s)
    Endo CDx Brush biopsy
    Intervention Description
    In patients with laryngeal lesion the brush biopsy will be taken with the standard cup biopsy - either in the clinic or in the OR. In LPR patients brush biopsy will be taken in the clinic.
    Primary Outcome Measure Information:
    Title
    Efficacy of EndoCDx brush
    Description
    Efficacy of EndoCDx brush biopsy as a diagnostic tool for laryngeal lesions compared to cup forceps biopsy and a diagnostic tool for LPR compared to double probe PH monitoring
    Time Frame
    3 months
    Secondary Outcome Measure Information:
    Title
    Assessment of pain
    Description
    Assessment of pain during EndoCDx brush biopsy under local anesthesia by Visual Analog Score for pain
    Time Frame
    6 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Age 18 or over patients suspected to suffer from LPR Patients with laryngeal/hypopharyngeal lesions. Exclusion Criteria: Patient refusal Patients with anatomical variants which precludes biopsy taking. Patients with allergy to lidocain-based local anesthesia agents.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Jacob Cohen, MD
    Organizational Affiliation
    Rambam Health Care Campus
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions

    We'll reach out to this number within 24 hrs